Institutional members access full text with Ovid®

Share this article on:

Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial

Mol, Ben W. MD, PhD; Walker, Sue P. MD, PhD

doi: 10.1097/AOG.0000000000002339
Departments: Letters

Department of Obstetrics and Gynaecology, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia

Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia

Financial Disclosure The authors did not report any potential conflicts of interest.

Guidelines for Letters. Letters posing a question or challenge to an article appearing in Obstetrics & Gynecology should be submitted within 8 weeks of the article’s publication online. Letters received after 8 weeks will rarely be considered. Letters should not exceed 350 words, including signatures and 5 references. A word count should be provided. A corresponding author should be designated (and contact information listed). Letters will be published at the discretion of the Editor. The Editor may send the letter to the authors of the original article so their comments may be published simultaneously. The Editor reserves the right to edit and shorten letters. A signed author agreement form is required from all authors before publication. Letters should be submitted using the Obstetrics & Gynecology online submission and review system, Editorial Manager (

© 2017 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.